Customer Connect Login
FIND AN ACCREDITED PROVIDER
Opioid treatment programs provide rehabilitation and medical support for persons addicted to opioid drugs. The duration of treatment should be based on the needs of the persons served and should take into consideration the benefit of medication-assisted treatment. The medications used to achieve treatment goals include methadone and buprenorphine, which are approved by the Food and Drug Administration (FDA) for the use in the treatment of opioid dependence.
Services are directed at reducing or eliminating the use of illicit drugs, criminal activity, and/or the spread of infectious disease while improving the quality of life and functioning of the persons served. Opioid treatment programs follow rehabilitation stages of sufficient duration to meet the needs of persons served.
In November 2001, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced that CARF was an approved accreditation provider for opioid treatment programs providing outpatient, residential, and detoxification services in the United States.
SAMHSA's approval of CARF accreditation is part of the federal government's 42 CFR, Part 8, which shifts regulatory oversight from the FDA to a national accreditation model under SAMHSA/Center for Substance Abuse Treatment (CSAT) oversight.
Please refer to the program descriptions for further details.
For more information on CARF opioid treatment program accreditation, please email firstname.lastname@example.org or call toll free (888) 281-6531.
© 2014 CARF International. All rights reserved.
Legal notices  Contact Us